NeoGenomics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $91.1M | $172.0M | $12.8M |
| FY2018 | $92.9M | $320.4M | $9.8M |
| FY2019 | — | $507.4M | $173.0M |
| FY2020 | — | $694.3M | $228.7M |
| FY2021 | — | $1.11B | $316.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $91.1M | $172.0M | $12.8M |
| FY2018 | $92.9M | $320.4M | $9.8M |
| FY2019 | — | $507.4M | $173.0M |
| FY2020 | — | $694.3M | $228.7M |
| FY2021 | — | $1.11B | $316.8M |